-

Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of OpenLab Sync, a new Lab Execution System (LES) that enables laboratories to digitally connect scientific workflows from method design through execution at the bench. OpenLab Sync extends Agilent’s OpenLab laboratory informatics portfolio beyond traditional data and sample management, enabling guided, standardized, and traceable execution of laboratory work in regulated environments.

As laboratories face increasing regulatory scrutiny, workforce turnover, and pressure to standardize operations across sites, many continue to rely on static, paper-based procedures that can introduce variability and risk. OpenLab Sync addresses growing demands for consistency, data integrity, and audit readiness in regulated environments by providing step-by-step, guided digital workflows that help reduce ambiguity in laboratory procedures while improving traceability of bench-level activities across teams and locations.

OpenLab Sync connects to USP MethodConnect through a plug-in developed by Agilent, making Agilent the first integrator of the platform. This integration enables USP’s machine-readable USP–NF test method content, including Monographs, General Chapters, and SOPs, to be ingested directly into guided protocols, transforming static SOPs into fully digital, operational procedures that help reduce ambiguity, supporting faster onboarding, greater confidence in execution, and improved scalability.

“Execution at the bench has remained one of the last gaps in laboratory digitalization. With OpenLab Sync, we are helping laboratories close that gap by supporting more consistent, confident, and compliant execution through a bench-friendly digital experience aligned with modern quality and data integrity expectations. Our collaboration with the United States Pharmacopeia helps laboratories become productive faster while maintaining confidence in both their methods and software,” said Shweta Shukradas, associate vice president of Automated Lab Productivity Solutions at Agilent.

"USP MethodConnect is designed to work across the laboratory informatics ecosystem, and this first integration with OpenLab Sync shows what that work looks like in practice. We look forward to working with integrators across the industry to make verified USP–NF workflows available to every lab that relies on them," said Vimala Raghavendran, vice president of Informatics Product Development at USP.

To further support lab managers, OpenLab Sync applies AI to streamline system setup and day-to-day use by helping reduce the time required to configure instrument integrations and guided workflows during installation. AI-enabled capabilities also provide advanced features such as powering instrument integration, workflow configuration, system monitoring, semantic search, and summarization.

Designed for pharmaceutical quality control and other regulated environments, OpenLab Sync helps organizations improve operational consistency, support compliance initiatives, and scale standardized workflows globally within Agilent’s unified OpenLab digital ecosystem.

OpenLab Sync is available globally as part of the Agilent OpenLab portfolio.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Media Contact
Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Media Contact
Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com

Social Media Profiles
More News From Agilent Technologies Inc.

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time...

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the...

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequencing...
Back to Newsroom